THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

No new reports of ills since return of Tysabri

MS drug had been linked to brain infection

By Christopher Rowland
Globe Staff / May 4, 2007

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

Ten months and 10,000 patients after the multiple sclerosis drug Tysabri returned to the market, there have been no new cases of the potentially fatal brain infection that led to the treatment's temporary withdrawal in February 2005, its makers said yesterday. (Full article: 451 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass